Efficacy of Low Dose Pegylated Interferon-alpha 2a Plus Ribavirin for the Treatment of Chronic Hepatitis C, Genotypes 2 or 3, in HIV-Coinfected Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 May 2010 Biomarkers information updated
- 04 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.